Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act)

HB 1477 establishes Maryland's Ibogaine Clinical Research Grant Program to fund clinical trials on ibogaine - a naturally occurring compound from the iboga plant - for treating opioid use disorder and other neurological conditions. The program, administered by the Maryland Department of Health in consultation with the Department of Veterans and Military Families, awards up to three annual grants to eligible research institutions in Maryland that meet specific criteria (including expertise in neurological disorders and substance use treatment) and require matching funds equal to the grant amount. Funding comes from $500,000 annually (fiscal years 2028-2030) in the Opioid Restitution Fund, with recipients required to conduct FDA-overseen trials and submit quarterly progress and financial reports. The bill aligns with the "Veterans Mental Health Innovations Act" title but does not restrict trials to veterans, focusing instead on broader neurological and opioid use disorder research.